The Six Most Shorted Stocks on the Nasdaq
courtesy of Sirius XM RadioShort sellers continue to hold huge positions not only in troubled companies like BlackBerry Ltd. (NASDAQ: BBRY), but also in such tech giants as Intel. As of April 30, the…
courtesy of Sirius XM RadioShort sellers continue to hold huge positions not only in troubled companies like BlackBerry Ltd. (NASDAQ: BBRY), but also in such tech giants as Intel. As of April 30, the…
Wikimedia CommonsShort sellers continue to hold huge positions not only in troubled companies like J.C. Penney Co. Inc. (NYSE: JCP), but also in blue chips like AT&T Corp. (NYSE:T) and Bank of America (NYSE: BAC). As…
ThinkstockShares CBS Corp. (NYSE: CBS) retreated Friday morning, following the media company’s first-quarter report late Thursday. At issue was a 9% year-on-year decline in CBS’s entertainment division to $2.3 billion, which helped drive overall…
ThinkstockWith interest rates still hovering just above multiyear lows, we continue to monitor ways for investors to get higher yields without chasing higher risk. The UBS Dividend Ruler stock list is constantly reviewed, and…
A new research report from Jefferies points out that free shipping was part of most transactions in 2013, so the focus has shifted to faster delivery. These companies are the leaders in same-day delivery.
Avago Technologies announced that it has completed its acquisition of LSI Corp. The latter will cease to be publicly traded after the closing bell Tuesday, and Avago will replace it on the S&P 500.
London-based financial information services company Markit is hoping to challenge larger competitors Bloomberg and Thomson Reuters by raising fresh capital via an IPO in the United States.
Not surprisingly, shares of KBR took a hit in early trading Monday after the company announced its intention to restate its consolidated financial statements for the year 2013.
For more than a decade, Apple was at the forefront of innovation as its products revolutionized their markets. But it is clear that its product introductions have slowed down, each one less revolutionary than…
Beleaguered beauty products company Avon has struggled for years to turn itself around. When Sheri McCoy was brought on as CEO a little more than two years ago, she promised a turnaround.
T-Mobile reported a bigger-than-expected net loss for the first-quarter 2014 before markets opened Thursday. It also said it added a record number of new subscribers in the period.
Mylan reported first-quarter 2014 results before markets opened Thursday. The generic drug maker reaffirmed its full-year EPS guidance and hinted at an acquisition by the end of the year.
In a new research note, the Quantitative Strategies Team at Jefferies offers a look behind the curtain at some of the stocks that could see heavy buying as the month winds down.
A bearish contingent on Wall Street says that says the PC game is all but over, and top chip stocks are in trouble. In a new research report, the analysts at Jefferies say not…
Bad news for Facebook: the percentage of teens active on the social media platform fell by 9% last year, according to a global survey of Internet users. Twitter does not have it quite so…
ThinkstockThe intense analysis of quantitative managers may seem like drudgery, but it can turn up absolute gems for investors looking for solid long ideas. In fact, firms like RBC use as much as 18…
Here are the top analyst upgrades, downgrades and initiations seen from Wall Street on Tuesday, April 29, 2014. They include Buffalo Wild Wings, Coca-Cola, DSW and Intuitive Surgical.
ThinkstockCoach Inc. (NYSE: COH) reported third-quarter fiscal 2014 results before markets opened Tuesday. The luxury accessories company posted adjusted diluted earnings per share (EPS) of $0.68 on revenues of $1.10 billion. In the same…
National Oilwell Varco tumbled Friday morning from a year-to-date high on Thursday on a narrow miss in first-quarter results. The pullback could offer an entry point for investors.
Shares of Mylan retreated first thing Monday morning, after the generic drugmaker's sweetened bid for Swedish drugmaker Meda was rejected.